Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
BioSpectrum Asia’s 23 Life Science trends to watch in 2023

BioSpectrum Asia recently published an article titled “23 Life Sciences trends to watch in 2023”, where a range of industry experts provided their predictions.
For 2023, IR Department’s Managing Director, Jane Lowe predicts that:
“I would expect to see life science companies that have been holding off on public market secondary raises come out of the woodwork to shore up their balance sheets. It feels like the market is starting to become more receptive to these raises, while the IPO market remains soft.” (Number 14. The booming of emerging companies).
To read the full article, CLICK HERE
